×
Entrez Id:
3014
Gene Symbol:
H2AX
H2AX
0.070
PosttranslationalModification
disease
BEFREE
γ-H2AX phosphorylation after bleomycin treatment in PBL did not differ between CRC and BC patients.
29052312
2018
×
Entrez Id:
1956
Gene Symbol:
EGFR
EGFR
0.400
Biomarker
disease
BEFREE
β-Galactoside α-2,6-sialyltransferase 1 (ST6Gal1) catalyzes EGFR sialylation that is associated with gefitinib resistance in colorectal cancers , and this was also investigated.
30187356
2018
×
Entrez Id:
6480
Gene Symbol:
ST6GAL1
ST6GAL1
0.080
Biomarker
disease
BEFREE
β-Galactoside α-2,6-sialyltransferase 1 (ST6Gal1 ) catalyzes EGFR sialylation that is associated with gefitinib resistance in colorectal cancers , and this was also investigated.
30187356
2018
×
Entrez Id:
3661
Gene Symbol:
IRF3
IRF3
0.020
Biomarker
disease
BEFREE
β-catenin regulates IRF3 -mediated innate immune signalling in colorectal cancer .
30004146
2018
SLC9A3R1
0.080
Biomarker
disease
BEFREE
β-catenin knockdown promotes NHERF1 -mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
29551770
2018
×
Entrez Id:
1499
Gene Symbol:
CTNNB1
CTNNB1
0.700
Biomarker
disease
BEFREE
β-Arrestins (Arrb) participate in the regulation of multiple signaling pathways, including Wnt/β-catenin , the major actor in human colorectal cancer initiation.
22315403
2012
×
Entrez Id:
5562
Gene Symbol:
PRKAA1
PRKAA1
0.080
Biomarker
disease
BEFREE
α-enolase promotes tumorigenesis and metastasis via regulating AMPK /mTOR pathway in colorectal cancer .
27996156
2017
×
Entrez Id:
5564
Gene Symbol:
PRKAB1
PRKAB1
0.060
Biomarker
disease
BEFREE
α-enolase promotes tumorigenesis and metastasis via regulating AMPK /mTOR pathway in colorectal cancer .
27996156
2017
×
Entrez Id:
5563
Gene Symbol:
PRKAA2
PRKAA2
0.060
Biomarker
disease
BEFREE
α-enolase promotes tumorigenesis and metastasis via regulating AMPK /mTOR pathway in colorectal cancer .
27996156
2017
×
Entrez Id:
6422
Gene Symbol:
SFRP1
SFRP1
0.400
Biomarker
disease
CTD_human
[The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
17923031
2007
×
Entrez Id:
6423
Gene Symbol:
SFRP2
SFRP2
0.400
Biomarker
disease
CTD_human
[The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
17923031
2007
×
Entrez Id:
6424
Gene Symbol:
SFRP4
SFRP4
0.330
Biomarker
disease
CTD_human
[The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
17923031
2007
×
Entrez Id:
6425
Gene Symbol:
SFRP5
SFRP5
0.310
Biomarker
disease
CTD_human
[The role of secreted Wnt-antagonist genes hypermethylation in early detection of colorectal tumor].
17923031
2007
×
Entrez Id:
1398
Gene Symbol:
CRK
CRK
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
5594
Gene Symbol:
MAPK1
MAPK1
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
25897
Gene Symbol:
RNF19A
RNF19A
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
26073
Gene Symbol:
POLDIP2
POLDIP2
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
9402
Gene Symbol:
GRAP2
GRAP2
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
7965
Gene Symbol:
AIMP2
AIMP2
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
10598
Gene Symbol:
AHSA1
AHSA1
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
1432
Gene Symbol:
MAPK14
MAPK14
0.100
Biomarker
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
×
Entrez Id:
8743
Gene Symbol:
TNFSF10
TNFSF10
0.400
AlteredExpression
disease
BEFREE
[Corrigendum] Lipocalin 2 inversely regulates TRAIL sensitivity through p38 MAPK‑mediated DR5 regulation in colorectal cancer .
30864690
2019
HNF1A-AS1
0.030
Biomarker
disease
BEFREE
[Corrigendum] Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma .
31257539
2019
×
Entrez Id:
125919
Gene Symbol:
ZNF543
ZNF543
0.010
Biomarker
disease
BEFREE
ZNF397OS and ZNF543 represented the top scoring associated events that were further validated in an independent cohort and exhibited strong correlation with BMI and excellent and statistically significant efficiency in the discrimination of obese from non-obese CRC patients (area under the curve >0.80; p < 0.05).
29717273
2019
×
Entrez Id:
1499
Gene Symbol:
CTNNB1
CTNNB1
0.700
Biomarker
disease
BEFREE
ZNF281 Regulates Cell Proliferation, Migration and Invasion in Colorectal Cancer through Wnt/β-Catenin Signaling.
31112017
2019